Prodways Tender Still Prices a Cheap Stub

Summary: ALPWG was quoted at EUR0.806 at the latest close displayed when checked on May 14, 2026 at 13:46 ICT, even after Prodways completed the sale of its Software business for EUR35 million on May 5, 2026 and then proposed a EUR20 million public tender offer at EUR1.10 per share on May 12, 2026. Because the offer covers only 35.13% of the capital, the real question is not whether a shareholder can sell one full share at EUR1.10. They cannot. The real question is what price the market is assigning to the smaller post-tender company. At today's quote, a holder accepted pro rata into the full offer is effectively left owning the surviving Prodways stub at about EUR0.647 per surviving share. A simple pro forma model using the disclosed continuing-operations balance sheet and the gross sale price implies the post-tender enterprise is being valued at only about 2.5x to 6.4x 2025 current EBITDA, depending on how much of the gross proceeds leaks away before or after the return. Prodways annual results, March 24, 2026 Completion of the Software sale, May 6, 2026 OPRA announcement, May 12, 2026 Yahoo Finance quote page for ALPWG.PA, checked May 14, 2026

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Prodways tender still prices a cheap stub	Europe / France small-cap industrial technology / asset sale / issuer tender	Prodways sold its Software business for EUR35 million, then proposed a EUR20 million tender at EUR1.10 for 35.13% of the capital, yet the latest quoted close was only EUR0.806. That quote implies the surviving stub is still being capitalized at roughly EUR0.647 per post-tender share.	Official sale-completion release dated May 6, 2026, official tender-project release dated May 12, 2026, official annual and Q1 disclosures, and live quote page checked May 14, 2026.	Independent expert report and AMF filing expected by end-May, AGM on June 17, 2026, then AMF compliance and launch.	The headline premium is not the edge. The edge is that the post-tender stub still screens too cheaply even under conservative cash-leakage assumptions.	The remaining 3D-printing businesses may deserve a structurally low multiple, and the company has not yet published a full post-sale pro forma balance sheet.
2	Destination XL hostile cash bid offers size but not certainty	U.S. small-cap retail / third-party tender offer	Zodiac launched an all-cash tender at $0.82 versus a last close of $0.6513, a gross spread of about 26%.	Official tender release dated May 12, 2026 and live quote page showing the May 11, 2026 close.	Offer expires June 19, 2026 unless extended.	The spread is big enough to matter.	This is not a board-backed signed merger. The bidder still needs holders to tender, and the company response surface is incomplete.
3	Avarga's scheme spread is almost gone	Broader Asia / Singapore holding company / scheme of arrangement	Avarga's privatization offers S$2.70 cash, but the latest quote page showed S$2.67, leaving almost no spread.	Official SGX joint announcement dated March 13, 2026 and live quote page checked May 14, 2026.	The scheme timetable is already mature.	The legal path is clearer than most hostile or conditional deals.	The spread is too thin to beat Prodways on payoff.
4	Denso's buyback is real, but public holders are not the customer	Japan large-cap auto parts / treasury tender	Denso's treasury tender is priced at JPY1,696, while the official Japan IR page showed a May 13, 2026 close of JPY1,878.	Official tender notice and official company quote page updated May 13, 2026.	Tender period runs through July 31, 2026.	The capital return is large.	The tender is intentionally priced below market to absorb Toyota-group stock, not to create a clean long for outside buyers.

Selected opportunity: Prodways tender still prices a cheap stub.

Why this one now: The sale is already closed, the tender size and price are now public, and the next gates are dated and observable.

What should surprise the reader: Even after a visible EUR35 million sale and a visible EUR20 million return plan, the market still prices the leftover Prodways business as if the sale mostly removed value rather than surfaced it.

Why This Is the Best Opportunity Right Now

Prodways is the cleanest mismatch on today's board because the market has already been given the hard part of the story.

The company has already sold the Software business. It has already said how much of the proceeds it intends to return. It has already set the proposed tender price. It has already disclosed the percentage of capital the offer would retire. The next steps are process, not discovery. Completion of the Software sale, May 6, 2026 OPRA announcement, May 12, 2026

The other lanes were real, but weaker. Destination XL offers a large headline spread, but it is a third-party cash tender without the comfort of a signed board-backed merger. Avarga is almost at the cash line already. Denso is a valid capital-allocation event, but not a public-holder bargain because the tender sits far below the tape. Prodways is the one setup where current price, corporate action, and residual-business value still disagree in a way that can be underwritten.

What Should Surprise the Reader

The surprise is not the 35.1% premium in the tender document.

The surprise is that the quote still does not capitalize the leftover company sensibly after you strip out the cash being offered back. This is not mainly a premium-arbitrage story. It is a stub-pricing story.

The Setup

Prodways spent 2025 trying to shrink itself into something more financeable. The first decisive step came on March 6, 2026, when it signed an agreement to sell AvenAo, its Software business, for EUR35 million. That business contributed EUR13.5 million of 2025 revenue and EUR3.9 million of recurring EBITDA, so the transaction crystallized real value rather than a token non-core disposal. Signing of the Software sale, March 6, 2026

Shareholders approved the sale on April 24, 2026. The company then announced on May 6, 2026 that all conditions had been lifted and the sale closed on May 5. Completion of the Software sale, May 6, 2026

The second step came on May 12, 2026, when Prodways proposed an issuer tender for EUR20 million of stock at EUR1.10 per share, enough to retire 18,181,818 shares or 35.13% of the capital. The AGM vote is scheduled for June 17, 2026, after the independent expert report and draft filing to the AMF expected by end-May. OPRA announcement, May 12, 2026

That leaves one underwriting question. What is the post-tender Prodways actually worth?

The Market Price

Market Level	Current Reading	Source / Timestamp	Why It Matters
`ALPWG` latest quoted close	EUR0.806	Yahoo Finance quote page checked May 14, 2026 at 13:46 ICT; page displayed close time 5:35:16 p.m. GMT+2	Current entry reference after the tender announcement.
Proposed tender price	EUR1.10	Prodways OPRA announcement, May 12, 2026	Public cash-return anchor.
Proposed tender size	EUR20.0 million	Prodways OPRA announcement, May 12, 2026	Cash actually earmarked for holders.
Shares outstanding	51,750,524	Prodways OPRA announcement, May 12, 2026	Official denominator for tender math.
Maximum shares repurchased	18,181,818	Prodways OPRA announcement, May 12, 2026	Equals 35.13% of capital.
Cash returned per current share if fully prorated	About EUR0.386	Calculated from 35.13% x EUR1.10	Shows how much of today's price is the tender leg.
Implied cost of the surviving share	About EUR0.647	Calculated from the latest quote, the tender price, and the 35.13% acceptance cap	This is the real stub valuation embedded in today's quote.
Sale price of the Software business	EUR35.0 million	Software sale completion release, May 6, 2026	Gross monetization event that funds the offer.
2025 continuing-operations revenue	EUR40.9 million	Prodways annual results, March 24, 2026	Scale of the business that remains after the sale.
2025 continuing-operations current EBITDA	EUR2.6 million	Prodways annual results, March 24, 2026	Core earnings anchor for the stub.
Year-end continuing-operations available cash	EUR5.25 million	Prodways annual results, March 24, 2026	Starting point for post-sale cash modeling.
Year-end continuing-operations net debt	EUR5.1 million	Prodways annual results, March 24, 2026	Lets you frame post-tender EV instead of stopping at equity value.
Modeled post-tender EV / EBITDA	About 2.5x to 6.4x	Calculated from the rows above assuming the group keeps the disclosed gross sale proceeds and then returns EUR20 million, with EUR0 million to EUR10 million of sale leakage	Even a conservative haircut leaves a modest multiple.

The Positioning

The main positioning fact is corporate, not speculative.

The GORGE family group has already told Prodways it intends to tender its shares. That group owns 24.98% of the capital, which is about 71% of the total offer capacity. This matters for two reasons. First, it makes the cancellation more credible because a large block is already leaning into the offer. Second, it reminds outside holders that the relevant asset is not a full exit at EUR1.10. Most of a minority position survives the offer and becomes a smaller listed stub. OPRA announcement, May 12, 2026

What I do not have is a reliable live read on short interest, stock-loan cost, or derivatives positioning for this Euronext Growth name during this run. This is not a squeeze thesis. It is a balance-sheet and corporate-action thesis.

The Catalyst

The catalyst path is visible and dated.

The sale closed on May 5 and was announced on May 6. The tender project was disclosed on May 12. Prodways expects the independent expert report and draft AMF filing by the end of May. The AGM is set for June 17, 2026. The board then plans to decide on launch, subject to the AMF compliance decision. Completion of the Software sale, May 6, 2026 OPRA announcement, May 12, 2026

That is enough to move price even before settlement. The market does not need to wait for cash in hand to revise the stub value upward. It only needs to stop treating the remaining business as if the sale stripped out most of the company's economic worth.

The Mispricing

Fact first. At EUR0.806, an investor buying one Prodways share today pays EUR0.806. If the proposed offer is fully subscribed, only 35.13% of that share is accepted at EUR1.10, which returns about EUR0.386 in cash. The remaining 64.87% survives. That leaves an implied cost basis of roughly EUR0.647 for each surviving post-tender share.

The inference is the real thesis. A surviving share bought through this route does not look like a business priced for perfection. It looks like a company the market still distrusts even after it monetized its richest Software asset and kept enough proceeds to remain funded.

The sale math sharpens the point. Prodways disclosed EUR5.25 million of continuing-op cash and EUR5.1 million of continuing-op net debt at year-end 2025. Add the gross EUR35 million sale price and subtract the proposed EUR20 million return, and the leftover group could still sit on roughly EUR15.15 million of net cash before any sale leakage. Against today's implied post-tender residual equity value of about EUR21.7 million, that would leave only about EUR6.6 million of enterprise value, or roughly 2.5x 2025 current EBITDA. Even if you haircut EUR10 million from the gross sale proceeds for taxes, fees, and other leakage, the implied multiple is still only about 6.4x EBITDA. Those are modeled figures, not company-disclosed pro formas, but they are built from disclosed numbers rather than wishful thinking. Prodways annual results, March 24, 2026

The market may be making a harsher judgment. It may believe that the Software disposal removed the best asset and left a structurally weak 3D-printing platform in dental, audiology, and industrial niches. That is the serious counterview. But today's price already leans far in that direction.

The Payoff Map

One possible expression is long ALPWG common stock.

That is the cleanest instrument because the thesis depends on a corporate tender, a shrinking share count, and a repricing of the surviving business. I did not verify a usable listed options market during this run, and an options structure is not required to express the edge.

The right mental model is not "EUR0.806 to EUR1.10." The right model is "EUR0.806 today for a mixed package of partial cash at EUR1.10 plus a surviving stub that still looks misvalued."

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	25%	`ALPWG` EUR1.00	+24.1%	1 to 3 months	Independent expert report is supportive, AGM approves the OPRA, AMF process advances without friction, and the market begins valuing the post-tender stub closer to EUR0.95 per surviving share.	Medium
Base Case	50%	`ALPWG` EUR0.92	+14.1%	1 to 3 months	The tender path holds, but the market still assigns only a middling value to the remaining 3D-printing operations.	Medium / High
Bottom Case	25%	`ALPWG` EUR0.70	-13.2%	1 to 3 months	AGM or AMF timing slips, the tender terms weaken, or new operating disclosures suggest the remaining business deserves a much lower multiple than the current model assumes.	Medium
Invalidation / Stop Condition	n/a	Sustained move below `ALPWG` EUR0.70	n/a	n/a	Material degradation in the return path, explicit evidence of major cash leakage, or a clear operational stumble that breaks the cheap-stub case.	Medium

Probability-weighted expected value: approximately +9.8% on price alone, using the scenario returns above.

Current market price / level: ALPWG EUR0.806 at the latest close displayed on the quote page checked May 14, 2026.

Timestamp: checked May 14, 2026 at 13:46 ICT. The quote page displayed close time 5:35:16 p.m. GMT+2.

Primary instrument: Prodways Group common stock, ALPWG.

Alternative expressions considered: waiting for the independent expert report or for AGM approval before entry. Waiting reduces process risk, but it also gives up part of the rerating if the market finally starts underwriting the stub correctly.

Confidence: Medium.

What Would Prove This Wrong

This thesis breaks if the offer path degrades or if the leftover business is worse than the sale-and-cash math implies.

It is wrong if one or more of the following happens:

the independent expert or the AMF process introduces material friction;
the AGM rejects or meaningfully shrinks the OPRA;
taxes, fees, or working-capital leakage consume far more of the EUR35 million proceeds than the market currently expects;
or 2026 operating updates show that the remaining businesses cannot even defend the modest profitability seen in 2025.

In that case, the market is not underpricing a stub. It is pricing a melt cube.

Risk Audit

Strongest counterargument: Prodways sold its best business and left investors with the slower, more cyclical pieces.
Most fragile assumption: enough of the sale proceeds really remain available for the tender and for post-tender balance-sheet support.
What the market may already know: minorities do not get a full exit at EUR1.10, and Euronext Growth industrial microcaps can stay cheap for longer than the math says they should.
What could lose money even if the thesis is directionally right: tender timing can slip, proration can disappoint, and the stub can drift while still being cheap.
Liquidity / execution risks: quoted volume was only 50,368 shares on the checked quote page, so sizing discipline matters. Yahoo Finance quote page for ALPWG.PA, checked May 14, 2026
Information reliability risks: the post-sale EV work in this note is a model built from disclosed balance-sheet data and the gross sale price, not a company-issued pro forma capitalization bridge.
Publish / revise / reject recommendation: Publish.

Bottom Line

Prodways looks misread because the market is still staring at the tender premium instead of the leftover company. The Software sale is done. The gross proceeds are known. The proposed return amount is known. The acceptance cap is known. At EUR0.806, the blended package still implies a surviving share priced around EUR0.647 and a post-tender enterprise that looks cheap even after conservative cash haircuts. This is not a full-cash arb. It is a post-tender stub trade hiding inside a public tender document.

Best trade strategy: Long ALPWG common stock. The edge is in the stub math, not in options.